Patients reaching patients through dialogue and education — virtually and in person. Gratitude to our sponsors Biogen, Genetech & Bristol Myers Squibb.
A new drug known as Kesimpta was approved for treating active RRMS in Scotland today. I was interviewed by The Courier, to give an insight into how the new drug will benefit myself and others with #MultipleSclerosis 🧡 thecourier.co.uk/fp/lifestyl…